import CPU from "@/components/icons/cpu";
import USMap from "@/components/icons/us-map";
export const fundDetails = [
  { label: "Morningstar Category", value: "Large Growth" },
  { label: "Fund Inception", value: "12/31/1984" },
  {
    label: "Exp Ratio (Gross)",
    value: "0.73%",
    date: "09/28/2024",
    hasTooltip: true,
  },
  {
    label: "Exp Ratio (Net)",
    value: "0.73%",
    date: "09/28/2024",
    hasTooltip: true,
  },
  { label: "NAV", value: "$20.60", date: "06/02/2025", hasTooltip: true },
  { label: "Minimum to Invest", value: "$0.00" },
  {
    label: "Turnover Rate",
    value: "55.00%",
    date: "01/31/2025",
    hasTooltip: true,
  },
  {
    label: "Portfolio Net Assets ($M)",
    value: "$29,465.73",
    date: "05/31/2025",
    hasTooltip: true,
  },
  {
    label: "Share Class Net Assets ($M)",
    value: "$21,799.68",
    date: "05/31/2025",
    hasTooltip: true,
  },
  {
    label: "12 Month Low-High",
    value: "$16.90 - $24.02",
    date: "05/31/2025",
    hasTooltip: true,
  },
];

export const fundManagerData = {
  manager: {
    name: "Christopher W. Lin",
    role: "Primary Manager",
    tenureStartDate: "09/16/2017",
    avatar: "/path/to/manager-avatar.jpg", // Optional
  },
  managedFunds: [
    {
      name: "VIP Balanced Portfolio - Investor Class",
      startDate: "12/05/2024",
    },
    {
      name: "Fidelity AdvisorÂ® Equity Growth Fund Class C",
      startDate: "04/11/2025",
    },
    { name: "VIP Growth Portfolio - Service Class 2", startDate: "04/11/2025" },
    // Add more funds as needed
  ],
  commentaryLinks: [
    { title: "Quarterly Fund Review", url: "#" },
    { title: "Portfolio Manager Q&A", url: "#" },
    { title: "Investment Approach", url: "#" },
  ],
};

export const fundOverviewData = {
  asOfDate: "04/30/2025",
  topSector: {
    name: "Information Technology",
    iconName: "Cpu", // Store icon name as string
    weight: null
  },
  topCountry: {
    name: "United States",
    weight: "93.66%",
    iconName: "MapPin" // Store icon name as string
  },
  objective: "Seeks capital appreciation.",
  strategy: `Normally investing at least 80% of assets in securities principally traded on NASDAQ or an over-the-counter
  market, which has more small and medium-sized companies than other markets. Investing more than 25% of total
  assets in the technology sector. Investing in either "growth" stocks or "value" stocks or both. Normally
  investing primarily in common stocks.`,
  risk: `Stock markets, especially foreign markets, are volatile and can decline significantly in response to adverse
  issuer, political, regulatory, market, or economic developments. The technology industries can be
  significantly affected by obsolescence of existing technology, short product cycles, falling prices and
  profits, and competition from new market entrants and general economic conditions.`,
  disclosures: `This description is only intended to provide a brief overview of the mutual fund. Read the fund's prospectus
  for more detailed information about the fund.`
};

// Icon mapping
export const iconComponents = {
  Cpu: CPU,
  MapPin: USMap
};

export const fundRisk = "Stock markets, especially foreign markets, are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. The technology industries can be significantly affected by obsolescence of existing technology, short product cycles, falling prices and profits, and competition from new markets, and general economic conditions. Foreign securities are subject to ,interest rate, currency exchange rate, economic, and political risks. The securities of smaller, less well-known companies can be more volatile than those of larger companies. The fund may have additional ,volatility because it can invest a significant portion of assets in securities of a small number of individual issuers.";

export const portfolioManagerInsights = [
  {
    id: 1,
    imageUrl: "chris-lin-bio", // Store paths instead of JSX
    imageClassName: "w-full h-[100px] object-cover",
    title: "Breakthrough biotechs with a bright future",
    description: "Fidelity's Chris Lin considers two biotech companies well-positioned to revolutionize drug development and the treatment of major diseases.",
    isLink: true
  },
  {
    id: 2,
    imageUrl: "chris-lin",
    imageClassName: "w-[135px] h-[135px] object-cover",
    title: "AI-Revolutionary",
    description: "Fidelity U.S. large cap growth portfolio managers see artificial intelligence as the most compelling multiyear investment theme that is going to drive major disruption across a variety of businesses.",
    isLink: true
  },
  {
    id: 3,
    imageUrl: "chris-lin",
    imageClassName: "w-[145px] h-[135px] object-cover",
    title: "U.S. Large Cap Growth: Innovation in Growth",
    description: "Fidelity U.S. large cap growth portfolio managers identify the major investment themes they expect to drive accelerating revenue and earnings growth over the next several years.",
    isLink: true
  }
];